267 related articles for article (PubMed ID: 17583393)
1. Use of tetanus toxoid as a differentiating infected from vaccinated animals (DIVA) strategy for sero-surveillance of avian influenza virus vaccination in poultry.
James CM; Foong YY; Mansfield JP; Fenwick SG; Ellis TM
Vaccine; 2007 Aug; 25(31):5892-901. PubMed ID: 17583393
[TBL] [Abstract][Full Text] [Related]
2. Generation of reassortant influenza vaccines by reverse genetics that allows utilization of a DIVA (Differentiating Infected from Vaccinated Animals) strategy for the control of avian influenza.
Lee CW; Senne DA; Suarez DL
Vaccine; 2004 Aug; 22(23-24):3175-81. PubMed ID: 15297071
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a positive marker of avian influenza vaccination in ducks for use in H5N1 surveillance.
James CM; Foong YY; Mansfield JP; Vind AR; Fenwick SG; Ellis TM
Vaccine; 2008 Oct; 26(42):5345-51. PubMed ID: 18723069
[TBL] [Abstract][Full Text] [Related]
4. Use of a tetanus toxoid marker to allow differentiation of infected from vaccinated poultry without affecting the efficacy of a H5N1 avian influenza virus vaccine.
James-Berry CM; Middleton D; Mansfield JP; Fenwick SG; Ellis TM
Vet Rec; 2010 Oct; 167(18):695-9. PubMed ID: 21257485
[TBL] [Abstract][Full Text] [Related]
5. Vaccination policy applied for the control of avian influenza in Italy.
Capua I; Marangon S
Dev Biol (Basel); 2003; 114():213-9. PubMed ID: 14677691
[TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
Jadhao SJ; Lee CW; Sylte M; Suarez DL
Vaccine; 2009 Oct; 27(44):6247-60. PubMed ID: 19686695
[TBL] [Abstract][Full Text] [Related]
7. Vaccines for List A poultry diseases: emphasis on avian influenza.
Swayne DE
Dev Biol (Basel); 2003; 114():201-12. PubMed ID: 14677690
[TBL] [Abstract][Full Text] [Related]
8. Generation and evaluation of an H9N1 influenza vaccine derived by reverse genetics that allows utilization of a DIVA strategy for control of H9N2 avian influenza.
Wu R; Chen Q; Zheng L; Chen J; Sui Z; Guan Y; Chen Z
Arch Virol; 2009; 154(8):1203-10. PubMed ID: 19543688
[TBL] [Abstract][Full Text] [Related]
9. Characterization and evaluation of avian influenza NS1 mutant virus as a potential live and killed DIVA (differentiating between infected and vaccinated animals) vaccine for chickens.
Brahmakshatriya VR; Lupiani B; Reddy SM
Vaccine; 2010 Mar; 28(12):2388-96. PubMed ID: 20064474
[TBL] [Abstract][Full Text] [Related]
10. Overview of avian influenza DIVA test strategies.
Suarez DL
Biologicals; 2005 Dec; 33(4):221-6. PubMed ID: 16257543
[TBL] [Abstract][Full Text] [Related]
11. Avian influenza vaccination in North America: strategies and difficulties.
Suarez DL; Lee CW; Swayne DE
Dev Biol (Basel); 2006; 124():117-24. PubMed ID: 16447502
[TBL] [Abstract][Full Text] [Related]
12. In ovo vaccination of chicken embryos with experimental Newcastle disease and avian influenza oil-emulsion vaccines.
Stone H; Mitchell B; Brugh M
Avian Dis; 1997; 41(4):856-63. PubMed ID: 9454919
[TBL] [Abstract][Full Text] [Related]
13. Application of new vaccine technologies for the control of transboundary diseases.
Swayne DE
Dev Biol (Basel); 2004; 119():219-28. PubMed ID: 15742632
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of infected and vaccinated animals (DIVA) using the NS1 protein of avian influenza virus.
Avellaneda G; Mundt E; Lee CW; Jadhao S; Suarez DL
Avian Dis; 2010 Mar; 54(1 Suppl):278-86. PubMed ID: 20521645
[TBL] [Abstract][Full Text] [Related]
15. Protective efficacy in chickens, geese and ducks of an H5N1-inactivated vaccine developed by reverse genetics.
Tian G; Zhang S; Li Y; Bu Z; Liu P; Zhou J; Li C; Shi J; Yu K; Chen H
Virology; 2005 Oct; 341(1):153-62. PubMed ID: 16084554
[TBL] [Abstract][Full Text] [Related]
16. Diagnosing avian influenza infection in vaccinated populations by systems for differentiating infected from vaccinated animals (DIVA).
Capua I; Cattoli G
Dev Biol (Basel); 2007; 130():137-43. PubMed ID: 18411945
[TBL] [Abstract][Full Text] [Related]
17. Use of strategic vaccination for the control of avian influenza in Pakistan.
Naeem K; Siddique N
Dev Biol (Basel); 2006; 124():145-50. PubMed ID: 16447505
[TBL] [Abstract][Full Text] [Related]
18. DIVA--a vaccination strategy enabling the detection of field exposure to avian influenza.
Capua I; Cattoli G; Marangon S
Dev Biol (Basel); 2004; 119():229-33. PubMed ID: 15742633
[TBL] [Abstract][Full Text] [Related]
19. Novel use of a N2-specific enzyme-linked immunosorbent assay for differentiation of infected from vaccinated animals (DIVA)-based identification of avian influenza.
Kwon JS; Kim MC; Jeong OM; Kang HM; Song CS; Kwon JH; Lee YJ
Vaccine; 2009 May; 27(24):3189-94. PubMed ID: 19446190
[TBL] [Abstract][Full Text] [Related]
20. A recombinant vesicular stomatitis virus replicon vaccine protects chickens from highly pathogenic avian influenza virus (H7N1).
Kalhoro NH; Veits J; Rautenschlein S; Zimmer G
Vaccine; 2009 Feb; 27(8):1174-83. PubMed ID: 19135116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
